1. Ocular surface changes in the treatment of rosacea: comparison between low-dose oral isotretinoin and doxycycline
- Author
-
Hélio Amante Miot, Fabíola Rosa Picosse, Fábio Mendonça Xavier Andrade, Camila Maia Valente, Laura Pires da Cunha, Denise de Freitas, Ediléia Bagatin, Fernanda Machado Bezerra, Universidade Federal de São Paulo (UNIFESP), and Universidade Estadual Paulista (Unesp)
- Subjects
Male ,Visual acuity ,Ocular surface ,Visual Acuity ,Administration, Oral ,Doxycycline/therapeutic use ,Eye ,Severity of Illness Index ,law.invention ,0302 clinical medicine ,Randomized controlled trial ,Isotretinoin/therapeutic use ,law ,Medicine ,Isotretinoin ,Meibomian Gland Dysfunction ,Doxycycline ,Blepharitis ,Doxycycline/administration & dosage ,Meibomian Glands ,General Medicine ,RE1-994 ,Middle Aged ,Ocular sur face ,Anti-Bacterial Agents ,Treatment Outcome ,Female ,Rosacea/drug therapy ,medicine.symptom ,medicine.drug ,Adult ,medicine.medical_specialty ,Isotretinoin/the rapeutic use ,Young Adult ,03 medical and health sciences ,Statistical significance ,parasitic diseases ,Severity of illness ,Humans ,Aged ,business.industry ,Isotretinoin/administration & dosage ,medicine.disease ,Dermatology ,eye diseases ,Ophthalmology ,Rosacea ,030221 ophthalmology & optometry ,Dermatologic Agents ,sense organs ,business - Abstract
Made available in DSpace on 2020-12-10T19:52:45Z (GMT). No. of bitstreams: 0 Previous issue date: 2020-03-01. Added 1 bitstream(s) on 2021-07-15T14:37:15Z : No. of bitstreams: 1 S0004-27492020000200109.pdf: 156349 bytes, checksum: 0f7a7745f1a8fb2a581a5473e92b1b11 (MD5) Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Purpose: To compare the impact of ocular changes between systemic treatment with doxycycline and low-dose oral isotretinoin in patients with moderate-to-severe papulopustular rosacea. Methods: Patients were randomized to receive either isotretinoin 0.3-0.4 mg/kg (group A) or doxycycline 100 mg/day (group B) for 16 weeks. Ocular symptoms were searched and evaluated, including best-corrected visual acuity (BCVA), Schirmer test, breakup time, rose bengal staining score, and meibomian gland dysfunction grading. The patients were retested at the end of treatment. Results: The present study included 39 patients (30 females and 9 males). Best-corrected visual acuity was > 20/30 in >90% of patients in both groups and did not change after treatment. After treatment, improvement in ocular symptoms and meibomian gland dysfunction was more pronounced in group B (p
- Published
- 2020
- Full Text
- View/download PDF